* This field is required

Respiratory Syncytial Virus (RSV) Infection

Solutions
Online Inquiry

Respiratory Syncytial Virus (RSV) Infection

Respiratory syncytial virus (RSV) infection is an infectious disease with a high prevalence. With a steadfast dedication to innovation, our company specializes in pioneering IVD reagents/kits and accompanying diagnostic equipment to tackle the complexities associated with RSV diagnosis. Serving as your trusted ally in RSV diagnostic exploration, we offer robust and inclusive solutions to fulfill your diverse scientific research requirements.

Overview of RSV Infection

Respiratory syncytial virus (RSV) is a seasonal and highly contagious virus with symptoms that are often similar to the common cold. However, in some cases, especially infants and people with compromised immune systems, RSV can cause serious respiratory complications. RSV is primarily spread through respiratory droplets, so close contact is a common mode of transmission. The rapid spread of RSV highlights the importance of early detection and effective management to prevent adverse outcomes.

Schematic diagram of the pathogenesis of RSV Infection.Fig. 1 Pathogenesis of RSV Infection. (Taleb, Sara A., et al., 2018)

IVD Development for RSV Infection

In vitro diagnostics (IVD) play a key role in the management of RSV infection, offering many advantages that aid in early identification, timely therapeutics, and effective control of the disease. In the realm of IVD development for RSV infection, the identification of specific diagnostic biomarkers and the utilization of precise detection methods are paramount in enabling accurate and timely diagnosis of this respiratory pathogen.

Genetic Testing

The fusion (F) protein of RSV is an extensively studied antigen pivotal in viral entry and membrane fusion processes. Acting as a dependable biomarker for RSV infection, the F protein is detectable through ELISA and immunofluorescence assay (IFA).

Antigen Testing

Biochemical Assays

The presence of RSV-specific antibodies, such as IgM and IgG, in serum samples may suggest a recent or previous RSV infection. Serological testing for the host's immune reaction to RSV offers valuable diagnostic insights.

Antibody Testing

Point-of-Care Testing

The presence of RSV RNA in respiratory samples indicates active viral replication and infection. Molecular techniques such as PCR and reverse transcription PCR can amplify viral RNA, providing highly sensitive and specific viral detection.

RNA Testing

IVD Kits for RSV Infection

In vitro diagnostic (IVD) kits for respiratory syncytial virus (RSV) infection are essential tools for accurate and efficient diagnosis of RSV. These kits generally encompass all necessary components for identifying distinct RSV biomarkers in samples, enabling swift and dependable virus detection. Presented below are a few illustrative instances.

Kits Description Detection Methods
RSV Antigen Detection Kit Qualitative detection of RSV specific antigen. ELISA, IFA
RSV Antibody Detection Kit Detection of IgA, IgG and IgM antibodies against RSV. ELISA
RSV RT-PCR Kit Qualitative detection of RSV-specific RNA and differentiation of RSV subtypes A and B. RT-PCR

Our Services

By conducting extensive research on diagnostic biomarkers associated with respiratory syncytial virus (RSV) infection, we are dedicated to innovating IVD solutions for precise detection and efficient management of this infectious disease. Our offerings encompass the design of antigen, antibody, and RNA test kits to facilitate rapid diagnosis and timely therapeutics of RSV infection. Our mission is to transform RSV infection diagnostics through the development of state-of-the-art IVD products.

Our portable and user-friendly point-of-care testing (POCT) empowers healthcare providers to swiftly diagnose RSV infections and implement timely interventions. Within the realm of companion diagnostics, our emphasis lies in crafting customized testing solutions to enhance and align with therapeutic interventions for RSV infections, ensuring personalized and effective care.
If you are interested in our services, please don't hesitate to reach out to us for further information and pricing details on the services we offer.

Reference

  1. Taleb, Sara A., et al. "Human respiratory syncytial virus: pathogenesis, immune responses, and current vaccine approaches." European Journal of Clinical Microbiology & Infectious Diseases 37 (2018): 1817-1827.

All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.